These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2418966)

  • 1. Tolerance to antineoplastic agents in children and adults.
    Marsoni S; Ungerleider RS; Hurson SB; Simon RM; Hammershaimb LD
    Cancer Treat Rep; 1985 Nov; 69(11):1263-9. PubMed ID: 2418966
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical phase I studies in oncology and hematology. Concepts, implementation and ethical considerations].
    Hanauske AR
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():68-70. PubMed ID: 8692122
    [No Abstract]   [Full Text] [Related]  

  • 4. Navelbine: a new step in cancer therapy?
    Armand JP; Marty M
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases].
    Neretto G; Agricola R; Giovanelli E; Poccardi G; Pellerito R; Furno F; Martinetto P; Pellegrino S; Daglio C; Tondolo M
    Recenti Prog Med; 1980 Oct; 69(4):431-57. PubMed ID: 7006015
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug management of malignant disease.
    Fennelly JJ
    Ir Med J; 1983 Jul; 76(7):326-31. PubMed ID: 6350216
    [No Abstract]   [Full Text] [Related]  

  • 7. Amsacrine in refractory acute leukemia.
    Griffin JD; Maguire ME; Mayer RJ
    Cancer Treat Rep; 1985; 69(7-8):787-9. PubMed ID: 3860296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurotoxicity of some antineoplastic agents].
    Mitolo-chieppa D; Ceci A
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1333-59. PubMed ID: 4458721
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibody therapy in hematology and oncology--2].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594
    [No Abstract]   [Full Text] [Related]  

  • 10. Should anthracyclines and dexrazoxane be used for children with cancer?
    van Dalen EC; van den Berg H; Raphaël MF; Caron HN; Kremer LC
    Lancet Oncol; 2011 Jan; 12(1):12-3. PubMed ID: 21195321
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytostatic treatment of malignant disease in children].
    Moe PJ
    Tidsskr Nor Laegeforen; 1970 Jun; 90(11):1196-201. PubMed ID: 4317930
    [No Abstract]   [Full Text] [Related]  

  • 12. The dose-response effect: a critical analysis.
    Amadori S
    Bone Marrow Transplant; 1991; 7 Suppl 2():154-6. PubMed ID: 1878690
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical drug development: an analysis of phase II trials, 1970-1985.
    Marsoni S; Hoth D; Simon R; Leyland-Jones B; De Rosa M; Wittes RE
    Cancer Treat Rep; 1987 Jan; 71(1):71-80. PubMed ID: 3791270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral complications of cancer chemotherapy--a review of 398 patients.
    Rosenberg SW
    J Oral Med; 1986; 41(2):93-7. PubMed ID: 3459832
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma.
    Tan CT; Hancock C; Steinherz PG; Steinherz LJ; Sorell M; Chan KW; Mondora A; Miller DR
    Cancer Res; 1982 Apr; 42(4):1579-81. PubMed ID: 6895864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic complications of induction therapy for leukemia and lymphoma.
    Cohen DG
    Cancer Nurs; 1983 Aug; 6(4):307-10. PubMed ID: 6554111
    [No Abstract]   [Full Text] [Related]  

  • 17. [Side effects of the drug therapy of leukemia].
    Lorie I; Khvatova NV
    Klin Med (Mosk); 1975 May; 52(5):135-9. PubMed ID: 1133987
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT; Hancock CH; Mondora A; Hoffman NW
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parasitic diseases in pediatric cancer patients].
    Bialek R
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S85-90. PubMed ID: 16288354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.